Nephrocare Health Services Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
₹529.25
58.00 (12.31%)
13.9% undervalued intrinsic discount
₹615.00
Fair Value
Price ₹529.25
AnalystConsensusTarget ₹615.00
Fair Value₹615.00
Share Pricen/a
NEPHROPLUS Community Narratives
AN
Fair Value
·Fair Value ₹615 13.9% undervalued intrinsic discount
Dialysis Demand And International Expansion Will Support A Positive Long Term View
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Dialysis Demand And International Expansion Will Support A Positive Long Term View
Catalysts About Nephrocare Health Services Nephrocare Health Services focuses on providing dialysis care through a mix of hospital partnerships, public private projects and international clinics. What are the underlying business or industry changes driving this perspective?Read more
AN

₹615
13.9% undervalued intrinsic discount
Fair Value
Revenue
15.28% p.a.
Profit Margin
22.17%
Future PE
31.15x
Price in 2029
₹488.05
Trending Discussion
Recently Updated Narratives
AN
Dialysis Demand And International Expansion Will Support A Positive Long Term View
Fair Value: ₹615 13.9% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Nephrocare Health Services Limited Key Details
About NEPHROPLUS
- Founded
- 2009
- Employees
- 3448
- CEO
- Website
View website
Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.